Tecon Biology 天康生物
6 significant filings since 31 May 2026: 3 on guarantee or financial assistance, 1 on earnings pre-announcement and 1 on acquisition or disposal, and 1 other kind. The latest, on 11 Sep 2026: 关于为全资子公司申请期货交割库业务提供担保的公告.
自 31 May 2026 起有 6 份重大公告：guarantee or financial assistance 3 份、earnings pre-announcement 1 份、acquisition or disposal 1 份，另有 1 类。最新一份（11 Sep 2026）：关于为全资子公司申请期货交割库业务提供担保的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 1 Sep 2024 | 国信证券 | 鲁家瑞,李瑞楠,江海航 | Buy 买入 | ▼ | Outperform 增持 |
| 4 May 2023 | 中邮证券 | 王琦 | Outperform 增持 | ▲ | Buy 买入 |
| 20 Jul 2021 | 华鑫证券 | 姚嘉杰 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 开源证券 | 陈雪丽 | Buy 买入 | 4 Sep 2026 | 3 | — |
| 太平洋 | 程晓东 | Buy 买入 | 30 Aug 2026 | 4 | — |
| 华安证券 | 王莺 | Buy 买入 | 9 Nov 2025 | 1 | — |
| 国信证券 | 鲁家瑞,李瑞楠,江海航 | Outperform 增持 | 7 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 9 reports. 每行为该券商近十二个月的最新研报；9 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。